Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:45 PM
Ignite Modification Date:
2025-12-24 @ 11:45 PM
NCT ID:
NCT07242651
Eligibility Criteria:
Inclusion Criteria:
1. Participants will be between 50 and 65 years of age.
2. The BMI of patients will range between 30 and 34.9.
3. Patients included in the study were diagnosed with essential hypertension for at least five years.
4. The patients will be in stage 1 hypertension under medical control, characterized by systolic blood pressure ranging from 140 to 159 mmHg and diastolic blood pressure ranging from 90 to 99 mmHg.
Exclusion Criteria:
1. Patients suffering from any unstable cardiovascular condition, such as uncontrolled arrhythmias or recent myocardial infarction.
2. Patients are diagnosed with secondary hypertension.
3. Patients with cognitive or physical impairments that prevent them from following instructions.
e) Patients who are taking beta-blockers and alpha-blockers because these medications may affect heart rate.
f) Individuals with endocrine disorders or any condition known to influence hormonal levels.
g) Patients are smokers. h) Malignant hypertension.
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
50 Years
Maximum Age:
65 Years
Study:
NCT07242651
Study Brief:
Protocol Section:
NCT07242651